Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Urothelial Cancer × enfortumab vedotin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 3 Urothelial Cancer 1 Ureteral Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Advanced Bladder Cancer 1

Interventions

Gemcitabine 3 Cisplatin 3 Carboplatin 3 pembrolizumab 2 vinflunine 1 tremelimumab 1 erdafitinib 1 enfortumab vedotin 1 durvalumab 1 Nivolumab 1 Ipilimumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04223856 2025-06-13

EV-302

Astellas Pharma Inc

Phase 3 Active not recruiting

886 enrolled 12 charts 1 FDA

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡